RecruitingNot applicableNCT06789705
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Studying Arginine vasopressin deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Basel, Switzerland
- Principal Investigator
- Mirjam Christ-Crain, Prof.University Hospital, Basel, Switzerland
- Intervention
- MDMA(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- University Hospital Basel, Basel, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06789705 on ClinicalTrials.govOther trials for Arginine vasopressin deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07361263Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyUniversity Hospital, Basel, Switzerland
- RECRUITINGPHASE1NCT04789148Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin DeficiencyElizabeth Austen Lawson
- RECRUITINGPHASE2NCT06808516Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy ControlsUniversity Hospital, Basel, Switzerland
- RECRUITINGPHASE2NCT06676774Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsUniversity Hospital, Basel, Switzerland
- RECRUITINGEARLY PHASE1NCT06460948Identifying Oxytocin Deficiency in Adults With Pituitary DiseaseElizabeth Austen Lawson
- RECRUITINGNCT06422975Registry of Patients in Shock Treated With VasopressinHospital Universitario 12 de Octubre